Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleEndocrine and Diabetes

Dextromethorphan and Dextrorphan Influence Insulin Secretion by Interacting with KATP and L-type Ca2+ Channels in Pancreatic β-Cells

Anne Gresch and Martina Düfer
Journal of Pharmacology and Experimental Therapeutics October 2020, 375 (1) 10-20; DOI: https://doi.org/10.1124/jpet.120.265835
Anne Gresch
University of Münster, Pharmaceutical and Medicinal Chemistry, Department of Pharmacology, Münster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martina Düfer
University of Münster, Pharmaceutical and Medicinal Chemistry, Department of Pharmacology, Münster, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Fig. 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 1.

    Effects of DXM and DXO on insulin secretion of mouse islets. (A) Acute treatment (1 hour) with DXM (100 µM) elevates insulin release in the presence of 3, 8, 10, and 15 mM glucose. (B) DXO (100 µM) induces stimulatory effects when exposure time was prolonged to 2.5 hours (1.5 hours preincubation and 1 hour acute application). (C) Insulin secretion (15 mM glucose) is not enhanced by 10 µM DXM but is reduced by 500 µM DXM. (D) Islets stimulated with 15 mM glucose and treated with 10 µM DXO do not show enhanced insulin secretion. (E) DXO and DXM elevate insulin release in the presence of 3 mM glucose and during the first and second phase in response to stimulation with 15 mM glucose (evaluated areas marked in gray). The number of independent islet preparations from different mice is given below each bar. The diagrams in (A–E) summarize the results of all series. Islets were isolated from female/male mice as follows: 10/8 (A), 6/6 (B), 9/9 (C), 5/7 (D), 5/3 (E). *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001 as indicated; #P ≤ 0.05 vs. 10 mM glucose (A) and vs. 500 µM DXM (C); ###P ≤ 0.001 vs. 15 mM glucose and all conditions with DXM (A and C), DXO (B and D); §P ≤ 0.05 (A) and P ≤ 0.001 (B) vs. 15 mM glucose. Please note that, for clearness of presentation, only the most relevant significances are included in parts (A, B, and E) of this figure.

  • Fig. 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 2.

    DXM and DXO increase the electrical activity of whole islets. (A) Representative membrane potential recording of an islet cultured on a microelectrode array. Islets were stimulated with 8 mM glucose and acutely treated with DXM (10 µM upper trace, 100 µM lower trace). (B) Evaluation of all experiments represented in (A). DXM (100 µM) elevates the FOPP considerably more than 10 µM DXM. (C) Same experimental setup as in (A and B) but with DXO instead of DXM. (D) Acute application of DXO (100 µM) elevates the FOPP substantially more than 10 µM DXO. The number in brackets stands for the number of evaluated islets. Islets were isolated from female/male mice as follows: 3/0 (B), 3/0 (D). ***P ≤ 0.001.

  • Fig. 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 3.

    DXM increases [Ca2+]c in whole islets. (A) Representative recordings of [Ca2+]c of an islet stimulated with 8 mM glucose alone (upper trace) or together with 100 µM DXM (lower trace). DXM was present 1 hour before and during the experiment as indicated. (B) Summary of all experiments represented in (A). DXM elevates mean Ca2+ at 8 mM glucose in islets after 1 hour of preincubation. Basal Ca2+ evaluated at the end of each measurement is also elevated in islets preincubated with 100 µM DXM. (C) DXM elevates mean Ca2+ at 3 mM glucose in islets after 1 hour of preincubation. (D) Summary of all experiments presented in (C). (E) Representative recordings of [Ca2+]c in islets stimulated with 8 mM glucose with acute application of 100 µM DXM (upper trace) or 100 µM DXO (lower trace). Compounds were added 15 minutes after starting the recording. (F) Summary of all experiments represented in (E). Evaluation of the last 5 minutes of treatment with DXM shows a relevant increase of mean [Ca2+]c. Acute application of 100 µM DXO slightly elevates mean [Ca2+]c of whole islets without an initial drop. The number of evaluated islets (B, D, and F) is given below each data plot. Islets were isolated from female/male mice as follows: 1/2 (B), 1/2 (D), 2/4 (F). **P ≤ 0.01; ***P ≤ 0.001.

  • Fig. 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 4.

    In contrast to DXO, DXM reduces Ca2+ action potentials in glucose-stimulated β-cells. (A) Representative membrane potential recording of a pancreatic β-cell in the perforated-patch configuration. DXM (100 µM) decreases the frequency of action potentials (8 mM glucose). (B) Summary of all experiments represented in (A). (C) Summary of analogous experiments with 15 mM glucose. A lower concentration of DXM (10 µM) does not affect the number of Ca2+ action potentials (APs). (D) Similar experiments as in (A) but with DXO. DXO (100 µM) has no effect on Ca2+ action potentials. The number in brackets represents the number of experiments with different cells from three mice. Islet cells were isolated from female/male mice as follows: 2/1 (B), 4/3 (C), 2/1 (D). *P ≤ 0.05; **P ≤ 0.01.

  • Fig. 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 5.

    DXM acutely decreases Ca2+ peak currents, and both compounds inhibit KATP channels of murine β-cells. (A) Representative voltage-clamp recording in the whole-cell configuration shows a decrease of the maximal Ca2+ current during administration of DXM (solid, black line) compared with the control condition (solid, gray line). (B) Summary of all experiments represented in (A). DXM (100 µM) reduces the Ca2+ current about 25%. (C and F) Representative recordings of KATP current measured in the whole-cell configuration. Administration of DXM (C) or DXO (F) directly decreases the KATP current. The current was identified as KATP current by the specific KATP channel inhibitor tolbutamide (Tolb; 100 µM). (D) Dose-response curve for the direct effect of DXM (10, 20, 50, and 100 µM) on KATP current. Statistically significant inhibition occurred with 50 and 100 µM. (E) Lack of antagonism of the DXM-induced inhibition by diazoxide (100 µM). (G) Summary of all experiments with 100 µM DXO. The number in brackets indicates the number of experiments with different cells from three mice. Islet cells were isolated from female/male mice as follows: 4/1 (B), 7/3 (D), 0/3 (E), 3/0 (G). *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001 vs. all other conditions, #P ≤ 0.05 vs. control and 20 µM DXM, ##P ≤ 0.01 vs. control.

  • Fig. 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Fig. 6.

    DXM and DXO affect [Ca2+]c and insulin release differently in SUR1-KO islets. (A) DXM (100 µM, 1.5 hours of preincubation and 1 hour of acute treatment) does not enhance insulin release (15 mM glucose) of murine SUR1-KO islets, whereas DXO (100 µM, 1.5 hours of preincubation and 1 hour of acute treatment) tends to have an elevating effect. (B) Representative recordings of [Ca2+]c of SUR1-KO islets stimulated with 8 mM glucose. The upper trace shows a drop in mean Ca2+ when DXM is added. By contrast, mean Ca2+ slightly rises after addition of DXO (lower trace) Nife: Nifedipine. (C) Summary of all experiments represented in (B). The numbers in brackets indicate independent islet preparations (A) or evaluated islets (C). Islets were isolated from female/male mice as follows: 6/4 (A), 5/2 (C). *P ≤ 0.05; ***P ≤ 0.001; ##P ≤ 0.01 vs. 15 mM glucose, ###P ≤ 0.001 vs. DXO and DXM.

Additional Files

  • Figures
  • Data Supplement

    • Supplemental Figure -

      Memantine (100 muM) acutely decreases KATP currents of murine Beta-cells.

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 375 (1)
Journal of Pharmacology and Experimental Therapeutics
Vol. 375, Issue 1
1 Oct 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Dextromethorphan and Dextrorphan Influence Insulin Secretion by Interacting with KATP and L-type Ca2+ Channels in Pancreatic β-Cells
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleEndocrine and Diabetes

NMDA Receptor Antagonists and β-Cells

Anne Gresch and Martina Düfer
Journal of Pharmacology and Experimental Therapeutics October 1, 2020, 375 (1) 10-20; DOI: https://doi.org/10.1124/jpet.120.265835

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleEndocrine and Diabetes

NMDA Receptor Antagonists and β-Cells

Anne Gresch and Martina Düfer
Journal of Pharmacology and Experimental Therapeutics October 1, 2020, 375 (1) 10-20; DOI: https://doi.org/10.1124/jpet.120.265835
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Insulin Inhibits Ubiquitination via USP14
  • PF-5190457 metabolite activity at the ghrelin receptor
  • Characterization of a Novel Weekly Basal Insulin
Show more Endocrine and Diabetes

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics